Vensana Capital® Portfolio News
Category: Vensana Capital® Portfolio News
Vensana Capital® Portfolio News
SpyGlass Pharma Raises $75 Million Series D Funding to Advance Its Long-term Drug Delivery Platform for Glaucoma Patients
Vensana Capital® Portfolio News
Rampart IC Secures Series B Financing to Fuel Strategic Growth and Expand Access to Radiation Safety Solutions
Vensana Capital® Portfolio News
Evident Vascular Raises Series B Financing to Advance AI-Powered Intravascular Ultrasound Platform Technology
Vensana Capital® Portfolio News
Alleviant Medical Secures $90 Million Financing to Expand Interventional Heart Failure Pivotal Trial Program
Vensana Capital® Portfolio News
Evident Vascular Welcomes Scott R. Ward to its Board of Directors
Vensana Capital® Portfolio News
Cleerly Raises $106 Million in Funding Led by Insight Partners to Revolutionize Heart Disease Care
Vensana Capital® Portfolio News
Okami Medical Appoints Bill Hoffman to its Board of Directors
Vensana Capital® Portfolio News
Okami Medical Announces Closing Of $32.5M Financing
Vensana Capital® Portfolio News
Stryker completes acquisition of Artelon, Inc.
Vensana Capital® Portfolio News
Stryker Announces Definitive Agreement to Acquire Artelon, Inc., Offering a Range of Soft Tissue Fixation Solutions for Orthopaedic Surgeons
Vensana Capital® Portfolio News
Clinical Trial Finds Artificial Intelligence-Guided Procedure for Persistent Atrial Fibrillation Superior to Current Standard of Care
Vensana Capital® Portfolio News
iVEAcare Launches with $27.5 Million in Series A Funding from Leading Medtech Investors
Vensana Capital® Portfolio News
Elucent Medical Secures Series C Funding to Advance Oncologic Surgery Innovation
Vensana Capital® Portfolio News
Trinity Capital Inc. Provides $25 Million Growth Capital To Moxe Health
Vensana Capital® Portfolio News
Boston Scientific Closes Acquisition of Relievant Medsystems, Inc.
Vensana Capital® Portfolio News
Evident Vascular Exits Stealth with $35 Million Series A Funding to Develop Vascular Imaging Platform
Vensana Capital® Portfolio News
Boston Scientific Announces Agreement to Acquire Relievant Medsystems, Inc.
Vensana Capital® Portfolio News
SpyGlass Pharma Completes $90 Million Series C Financing to Advance Novel Treatments for Glaucoma and other Chronic Ophthalmic Diseases
Vensana Capital® Portfolio News
Artelon, Inc. Secures $20M in Funding to Advance Surgical Treatment of Joint Instability
Vensana Capital® Portfolio News
